Overview

  • Product name

    Anti-Hemopexin antibody [EPSISR42]
    See all Hemopexin primary antibodies
  • Description

    Rabbit monoclonal [EPSISR42] to Hemopexin
  • Host species

    Rabbit
  • Tested applications

    Suitable for: WB, IPmore details
    Unsuitable for: ICC/IF or IHC-P
  • Species reactivity

    Reacts with: Mouse, Rat, Human
  • Immunogen

    Synthetic peptide within Human Hemopexin aa 50-150. The exact sequence is proprietary.

  • Positive control

    • Human plasma and Human serum lysates.
  • General notes

     

     

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents.

    This product is a recombinant rabbit monoclonal antibody.

Properties

Applications

Our Abpromise guarantee covers the use of ab150401 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/1000 - 1/10000. Predicted molecular weight: 51 kDa.
IP 1/40.
  • Application notes
    Is unsuitable for ICC/IF or IHC-P.
  • Target

    Images

    • All lanes : Anti-Hemopexin antibody [EPSISR42] (ab150401) at 1/1000 dilution

      Lane 1 : Human plasma lysate
      Lane 2 : Human serum lysate

      Lysates/proteins at 10 µg per lane.

      Predicted band size: 51 kDa

    References

    This product has been referenced in:

    • Vercellotti GM  et al. Hepatic Overexpression of Hemopexin Inhibits Inflammation and Vascular Stasis in Murine Models of Sickle Cell Disease. Mol Med 22:N/A (2016). Read more (PubMed: 27451971) »
    See 1 Publication for this product

    Customer reviews and Q&As

    There are currently no Customer reviews or Questions for ab150401.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
    For licensing inquiries, please contact partnerships@abcam.com

    Sign up